Allianz Asset Management’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-24,000
Closed -$378K 2215
2022
Q2
$378K Hold
24,000
﹤0.01% 1957
2022
Q1
$365K Hold
24,000
﹤0.01% 2186
2021
Q4
$369K Buy
+24,000
New +$316K ﹤0.01% 2310
2017
Q3
Sell
-177,565
Closed -$1.37M 2702
2017
Q2
$1.37M Sell
177,565
-375,045
-68% -$3.17M ﹤0.01% 2118
2017
Q1
$4.98M Sell
552,610
-7,880
-1% -$82.1K ﹤0.01% 1626
2016
Q4
$6.06M Buy
560,490
+178,862
+47% +$2.38M 0.01% 1577
2016
Q3
$6.23M Buy
+381,628
New +$5.37M 0.01% 1533
2013
Q4
Sell
-148,500
Closed -$1.1M 1925
2013
Q3
$1.1M Buy
148,500
+42,500
+40% +$331K ﹤0.01% 1356
2013
Q2
$921K Buy
+106,000
New +$681K ﹤0.01% 1370

Other funds holding NPTN

Allianz Asset Management's NPTN Position: Q3 2022 in Review

Allianz Asset Management sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 24,000 shares — an estimated $378K sold.

Allianz Asset Management first reported a position in NPTN in Q2 2013 and held it in 9 quarters. The position peaked at $6.23M in Q3 2016. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.

  • Allianz Asset Management reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
  • Allianz Asset Management sold 24,000 NEOPHOTONICS CORP shares in Q3 2022, an estimated $378K.
  • Allianz Asset Management first reported a position in NEOPHOTONICS CORP in Q2 2013 and held it in 9 quarters.
  • Allianz Asset Management's NEOPHOTONICS CORP position peaked at $6.23M in Q3 2016.
  • 2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.

Based on Allianz Asset Management's 13F filing for Q3 2022, filed 8 Nov 2022.